These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 16132615)

  • 21. Marine lysozyme from a marine bacterium that inhibits angiogenesis and tumor growth.
    Ye J; Wang C; Chen X; Guo S; Sun M
    Appl Microbiol Biotechnol; 2008 Jan; 77(6):1261-7. PubMed ID: 18043915
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapamycin inhibits hepatectomy-induced stimulation of metastatic tumor growth by reduction of angiogenesis, microvascular blood perfusion, and tumor cell proliferation.
    Rupertus K; Dahlem C; Menger MD; Schilling MK; Kollmar O
    Ann Surg Oncol; 2009 Sep; 16(9):2629-37. PubMed ID: 19551445
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lebectin, a Macrovipera lebetina venom-derived C-type lectin, inhibits angiogenesis both in vitro and in vivo.
    Pilorget A; Conesa M; Sarray S; Michaud-Levesque J; Daoud S; Kim KS; Demeule M; Marvaldi J; El Ayeb M; Marrakchi N; Béliveau R; Luis J
    J Cell Physiol; 2007 May; 211(2):307-15. PubMed ID: 17323383
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Broad antitumor activity in breast cancer xenografts by motesanib, a highly selective, oral inhibitor of vascular endothelial growth factor, platelet-derived growth factor, and Kit receptors.
    Coxon A; Bush T; Saffran D; Kaufman S; Belmontes B; Rex K; Hughes P; Caenepeel S; Rottman JB; Tasker A; Patel V; Kendall R; Radinsky R; Polverino A
    Clin Cancer Res; 2009 Jan; 15(1):110-8. PubMed ID: 19118038
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-angiogenic action of plasma hyaluronan binding protein in human umbilical vein endothelial cells.
    Jeon JW; Song HS; Moon EJ; Park SY; Son MJ; Jung SY; Kim JT; Nam DH; Choi-Miura NH; Kim KW; Kim YJ
    Int J Oncol; 2006 Jul; 29(1):209-15. PubMed ID: 16773202
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor endothelial cells are targets for selective therapies: in vitro and in vivo models to evaluate antiangiogenic strategies.
    Dutour A; Rigaud M
    Anticancer Res; 2005; 25(6B):3799-807. PubMed ID: 16309166
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Retinoic acid inhibits angiogenesis and tumor growth of thyroid cancer cells.
    Hoffmann S; Rockenstein A; Ramaswamy A; Celik I; Wunderlich A; Lingelbach S; Hofbauer LC; Zielke A
    Mol Cell Endocrinol; 2007 Jan; 264(1-2):74-81. PubMed ID: 17101211
    [TBL] [Abstract][Full Text] [Related]  

  • 28. cis-3, 4', 5-Trimethoxy-3'-aminostilbene disrupts tumor vascular perfusion without damaging normal organ perfusion.
    Durrant D; Corwin F; Simoni D; Zhao M; Rudek MA; Salloum FN; Kukreja RC; Fatouros PP; Lee RM
    Cancer Chemother Pharmacol; 2009 Jan; 63(2):191-200. PubMed ID: 18365199
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vesnarinone inhibits angiogenesis and tumorigenicity of human oral squamous cell carcinoma cells by suppressing the expression of vascular endothelial growth factor and interleukin-8.
    Harada K; Supriatno ; Yoshida H; Sato M
    Int J Oncol; 2005 Dec; 27(6):1489-97. PubMed ID: 16273203
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A low molecular weight polysaccharide isolated from Agaricus blazei suppresses tumor growth and angiogenesis in vivo.
    Niu YC; Liu JC; Zhao XM; Wu XX
    Oncol Rep; 2009 Jan; 21(1):145-52. PubMed ID: 19082455
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beta-carotene inhibits tumor-specific angiogenesis by altering the cytokine profile and inhibits the nuclear translocation of transcription factors in B16F-10 melanoma cells.
    Guruvayoorappan C; Kuttan G
    Integr Cancer Ther; 2007 Sep; 6(3):258-70. PubMed ID: 17761639
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibitory effect of glycolipids from spinach on in vitro and ex vivo angiogenesis.
    Matsubara K; Matsumoto H; Mizushina Y; Mori M; Nakajima N; Fuchigami M; Yoshida H; Hada T
    Oncol Rep; 2005 Jul; 14(1):157-60. PubMed ID: 15944783
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improved therapeutic responses for liposomal doxorubicin targeted via thrombospondin peptidomimetics versus untargeted doxorubicin.
    Rivera-Fillat MP; Reig F; Martínez EM; Grau-Oliete MR
    J Pept Sci; 2010 Jul; 16(7):315-21. PubMed ID: 20552567
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-angiogenic effect of pyridoxal 5'-phosphate, pyridoxal and pyridoxamine on embryoid bodies derived from mouse embryonic stem cells.
    Matsubara K; Mori M; Akagi R; Kato N
    Int J Mol Med; 2004 Nov; 14(5):819-23. PubMed ID: 15492851
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Antitumor effect of levamisole].
    Hisano G; Yata K; Tsubura E
    Gan To Kagaku Ryoho; 1982 Jul; 9(6):1119-20. PubMed ID: 7184443
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phosphatase inhibitors with anti-angiogenic effect in vitro.
    Sylvest L; Bendiksen CD; Houen G
    APMIS; 2010 Jan; 118(1):49-59. PubMed ID: 20041871
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiangiogenic drugs increase xenograft aggressiveness.
    Cancer Discov; 2012 Mar; 2(3):OF3. PubMed ID: 22586000
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The anthraquinone derivative Emodin inhibits angiogenesis and metastasis through downregulating Runx2 activity in breast cancer.
    Ma J; Lu H; Wang S; Chen B; Liu Z; Ke X; Liu T; Fu J
    Int J Oncol; 2015 Apr; 46(4):1619-28. PubMed ID: 25673059
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The combination 5-fluorouracil/levamisole induces enhanced rat Kupffer cell-mediated cytotoxicity in vitro against the syngeneic colon adenocarcinoma cell line CC531.
    Schuurman B; Sirovich I; Heuff G; van der Wilt CL; Peters GJ; Beelen RH; Meyer S
    J Surg Oncol; 1995 Nov; 60(3):180-4. PubMed ID: 7475068
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neamine inhibits xenografic human tumor growth and angiogenesis in athymic mice.
    Hirukawa S; Olson KA; Tsuji T; Hu GF
    Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8745-52. PubMed ID: 16361562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.